Real-time enrollment status for this urothelial carcinoma bladder clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:35 AM UTC
| NCT Number | NCT06586255 |
| Recruiting Status | Recruiting |
| Condition | Urothelial Carcinoma Bladder |
| Phase | PHASE1 |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of August 28, 2026: Clinical trial NCT06586255 is currently recruiting participants. This phase1 study for urothelial carcinoma bladder is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06586255 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06586255 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.